Micropaque Ct (Barium Sulfate)

Barium sulfate works by providing high‑density coating of the gastrointestinal mucosa. Its high atomic number strongly absorbs X‑ray photons, creating a bright, white outline on radiographic images. This contrast improves the detection of structural abnormalities, lesions, and functional disorders within the GI tract.

The dose of Micropaque Ct is determined by the prescribing clinician based on the specific imaging protocol, patient age, weight, and the anatomical region to be examined. The prescriber selects the appropriate volume and concentration to achieve optimal contrast without exceeding safety limits.

The safety of Micropaque Ct in pregnancy and lactation has not been definitively established. Because it is a radiopaque agent, it should be used only if clearly needed and after careful risk‑benefit assessment by the healthcare provider. Consultation with a specialist is recommended.

To order Micropaque Ct, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Micropaque Ct (barium sulfate) is a non‑ionic, high‑density oral/rectal contrast agent, whereas iodine‑based agents are typically used intravenously for vascular imaging. Barium provides superior coating of the GI lumen and is preferred for detailed mucosal assessment, while iodine agents are chosen for vascular or soft‑tissue contrast.

Micropaque Ct should be stored at room temperature, below 25 °C, in its original container. Protect the suspension from moisture, direct sunlight, and extreme temperature fluctuations. Keep the product tightly sealed when not in use to maintain suspension stability.

Micropaque Ct is supplied as a suspension that can be ingested orally or introduced rectally, depending on the imaging study. The prescribed volume is mixed with water if needed, and the patient is instructed to retain the suspension for a specified time to allow adequate coating of the gastrointestinal lining before imaging.

Serious risks include allergic reactions such as rash or anaphylaxis, severe abdominal pain indicating possible obstruction, aspiration of the suspension into the lungs, and significant dehydration if large volumes are used without adequate fluid intake. Prompt medical evaluation is required if any of these events occur.

Micropaque Ct should be avoided in patients with known hypersensitivity to barium sulfate, complete bowel obstruction, severe constipation without medical supervision, or those at high risk of aspiration (e.g., severe dysphagia). Clinicians should also exercise caution in pregnant or lactating women when alternative imaging options are available.